Saturday , 8 May 2021

Review: Sitagliptine-DPP-4 Inhibitor

About author
Jeevan Menaria*, Mukesh Dhakar, Lalit Singh Ranawat
Geetanjali Institute of Pharmacy, Udaipur

Abstract
In these therapeutic time peoples are suffering from various disease. Fight against disease doing some as a research work, discovery of new drugs. In these time biabetes is serious disease. It is two type insuln dependent and non insulin dependent. Sitagliptin is the DPP4 inhibitor which act as  Glucagon increases blood glucose levels, and DPP-4 inhibitors reduce glucagon and blood glucose levels. So these drugs are useful for treatmenat of diabtes.
Key words : Disease, research, diabetes, saxigliptine

Scroll To Top